Department of Pharmacognosy, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria.
J Ethnopharmacol. 2022 Jan 30;283:114686. doi: 10.1016/j.jep.2021.114686. Epub 2021 Sep 24.
The choice of extraction solvent is a significant consideration in ethnomedicine as optimal extraction could influence the bioactivity of the herbal medicinal product.
This study investigated the possible influence of the choice of solvents (methanol and water) for extracting MAMA Powder (MP) against Plasmodium berghei-infected mice to optimize its antimalarial activity and for developing other pharmaceutical dosage forms.
Aqueous and methanol extracts of MP, obtained through the decoction and soxhlet methods, respectively, were subjected to liquid chromatography-mass spectroscopy (LC-MS) for their respective fingerprints. The antimalarial activities of the methanol and aqueous extracts (12.5-100 mg/kg) were evaluated orally using the chemosuppressive test model on chloroquine-sensitive Plasmodium berghei-infected mice. The methanol extract was subjected to the established infection and prophylactic antimalarial tests with chloroquine (10 mg/kg) and pyrimethamine (1.25 mg/kg) as positive controls, respectively. The aqueous extract was investigated in chloroquine-resistant P. berghei using the chemosuppressive (12.5-800 mg/kg) and established infection (25-400 mg/kg) antimalarial models.
The LC-MS fingerprints of both aqueous and methanol extracts revealed similar indole alkaloid contents. Chemosuppressive activity of the aqueous extract (75.3%) was significantly (p < 0.05) higher than the methanol extract (67.6%). In the chloroquine-resistant P. berghei infection experiments, the aqueous extract (400 mg/kg) exhibited significant parasite clearance (72%).
The study concluded that the water extract with higher antimalarial activity could be optimized for chloroquine-resistant malaria and can thus facilitate the production of liquid and solid dosage forms.
在民族医学中,选择提取溶剂是一个重要的考虑因素,因为最佳提取方法可能会影响草药药物的生物活性。
本研究旨在探讨选择溶剂(甲醇和水)提取 MAMA 粉(MP)对抗伯氏疟原虫感染小鼠的可能影响,以优化其抗疟活性,并开发其他药物剂型。
通过煎煮和索氏提取法分别获得 MP 的水提物和甲醇提物,通过液相色谱-质谱(LC-MS)进行各自的指纹图谱分析。采用化学抑制试验模型,对氯喹敏感的伯氏疟原虫感染小鼠进行口服甲醇和水提取物(12.5-100mg/kg)的抗疟活性评价。甲醇提取物分别以氯喹(10mg/kg)和乙胺嘧啶(1.25mg/kg)作为阳性对照进行建立感染和预防性抗疟试验。水提取物在氯喹耐药的伯氏疟原虫中进行化学抑制(12.5-800mg/kg)和建立感染(25-400mg/kg)抗疟模型。
水提物和甲醇提取物的 LC-MS 指纹图谱显示出相似的吲哚生物碱含量。水提物的化学抑制活性(75.3%)显著高于甲醇提物(67.6%)(p<0.05)。在氯喹耐药的伯氏疟原虫感染实验中,水提物(400mg/kg)表现出显著的寄生虫清除率(72%)。
研究表明,具有更高抗疟活性的水提取物可用于优化治疗氯喹耐药性疟疾,并有助于生产液体和固体剂型。